Triall at Digital Demo Day 🇩🇪 We look forward to joining #DDD23 this month to #demo our Clinical Insights Exchange prototype. Next to our booth, we've been selected to participate in the pre-finals of the #startup #pitch competition. 📅 Thursday Aug 17 📍 Düsseldorf, Germany

#TRLinsights - 90% of study participants indicated that receiving an act of appreciation increased satisfaction. Incorporating items that show gratitude & engage patients throughout the clinical trial journey can result in improved retention & adherence.

t.co

Did you catch our AMA? 📺💬 In our last #community #AMA, Triall CEO Hadil talks about the role of $TRL in clinical trial data re-use and automated patient reimbursement. ⚡️ Trade $TRL at

t.co

👇 Check out the full recording:

t.co

#TRLInsights - 1/3 of participants do not feel valued for their contribution to clinical research. This can impact retention, satisfaction, and overall adherence. @TranscelerateB has therefore developed a best practices #Gratitude #Toolkit. 👇 Source:

t.co

Did you catch our new staking pool? 💎 Join our new 8% APR #staking pool on #BSC at

t.co

New to $TRL staking? ✅ Whitelist yourself:

t.co

📋 Read the guide:

t.co

Staking powered by @FerrumNetwork

#TRLInsights - Phase 3 clinical trials collect on average 3x more data compared to 10 years ago. A typical Phase 3 study now collects over 3.6M data points as a result of complex study designs and a higher volume and variety of data sources. Source:

t.co

New staking pool is live 💎 Our #staking pool is now open at

t.co

The 8% APR pool on #BSC will run for 100 days. New to $TRL staking? ✅ Whitelist yourself

t.co

📋 Read the guide

t.co

Staking powered by @FerrumNetwork

Triall AMA: Announcing the winners 🏆📺💬 And that’s a wrap! We look back on another great session with exceptional questions from the Triall community. Now, we’re excited to announce the winners of our 15th community AMA. AMA winner list @Pim2000 @Capcosmos @Anakbiskuat0006 @Algojali @Pepayacc How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: youtube.com/watch?v=bgXhQPHGDjc When is the next AMA? Our next community AMA will be hosted by the end of this month (date TBA). 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall Insights 🔍 55% of sponsors and CROs report using Risk-Based Quality Management (RBQM) in their clinical trials. 78% trust that RBQM improves study quality, while 64% believe RBQM increases efficiency & cost savings, and 53% trust it can reduce timelines. Source: csdd.tufts.edu/impact-reports ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Lessons learned DIA 2023 👩‍💻 Our team looks back on a thought-provoking week at #DIA2023. We had the honour of hosting two sessions where we explained how blockchain and SSI can de-risk operations, incentivise data sharing, and empower patients. We also joined various other sessions. Here are some of our key insights: ✅ It’s more difficult to predict clinical trial performance than ever before. Risks and cycle times continue to increase. There's a large need for novel methods to de-risk & improve study predictability. ✅ We need to have incentives in place to make it worthwhile for industry, care providers, and patients to share their data and we have to build the infrastructure to enable this. ✅ There’s a growing number of industry initiatives that focus on returning individual participant data to boost patient empowerment and control. 🗣 Support us on Twitter:

twitter.com

#blockchainforhealth #TRL

And we’re live once again! 🚨📺💬 Tune in to this month’s live community AMA 👇

www.youtube.com

New staking pool next week 💎 Get ready to stake! A new $TRL staking pool will be opening on Wednesday, July 12 at 18:00 UTC. The BSC Holder 8 (8% APR) pool will launch on BSC and runs for 100 days. New to $TRL staking? ✅ Whitelist yourself at bit.ly/TRLwhitelist 📋 Read the guide at bit.ly/stakingTRL Staking tech is powered by Ferrum Network. ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall Insights 🔍 According to the IQVIA Institute, 1.8 million people participated in clinical trials across 2022. The last 4 years have seen record-breaking numbers of participants in clinical research. Triall offers a single-access platform where clinical trial sponsors, sites, and participants can securely interact and collaborate on key study activities. Source: iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Announcing the next community AMA 📺💬 We’ve arrived at the end of June so it’s time for our monthly AMA! On July 5 at 13:00 UTC, Triall will host its 15th community AMA on YouTube, answering live and pre-submitted questions from the TRL community. 🎙 AMA Guests - Hadil Es-Sbai, Chief Executive Officer - Niels Klomp, Chief Technology Officer - Dr. Arno Bisschop, Chief Medical Officer - Raymond van der Waal, Head of Strategic Partnerships 📬 AMA Questions Submit your questions here: bit.ly/TRLvidAMA15 The 5 best questions get $50 in TRL tokens💰 🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Thank you for joining us at DIA 2023 🔥👏 Big shoutout to all who joined and engaged in our workshop and presentation yesterday at #DIA2023. We were highly impressed by the quality and diversity of questions from the audience. Let’s together build towards a future of open, verifiable, and patient-centric clinical research with #blockchain and #SSI. ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Zooming in on decentralization at DIA 2023 🔍 Clinical trials are moving outside of the clinic, a concept often referred to as decentralization. But how ‘decentralized’ is this new operating model? And what are the benefits for the patient experience, if any? This Monday at #DIA2023, we will unpack the meaning of decentralization together with global CRO Worldwide Clinical Trials. We’ll take a unique angle by covering how decentralized and privacy-enhancing technologies such as blockchain and SSI can open a new phase of open, verifiable, and patient-centric clinical research. Time & location: 📆 Mon Jun 26 16:15-17:15 EDT 📍 Room 253 A Boston Convention and Exhibition Center ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

CIX showcase at DBC Conference 2023 🇳🇱 The Dutch Blockchain Coalition (DBC) is hosting its annual conference next week, covering the latest developments within digital trust, #SSI, product passports, #DAOs, and more. We’re proud to have been selected to showcase a prototype of our Clinical Insights Exchange (#CIX), a federated data marketplace for exchanging clinical data assets and analytics services in a trusted, privacy-friendly environment. Time & location: 📅 Monday June 26, 12:30-18:30 CEST 📍 Head office ABN AMRO Bank, Amsterdam Also attending? Connect with us for a live presentation! ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Ensuring tamper-resistant AI 🤖 We demonstrated how blockchain can secure clinical trial data integrity, but how about algorithms? In last month’s AMA, Triall CTO Niels explains how the Clinical Insights Exchange (CIX) will have tamper-resistant integrity checks to ensure (AI) algorithms are vetted and certified. Missed the live session? 👉 Check out the full recording: youtube.com/watch?v=o9Whlo6NYxA ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Join us at DIA 2023 in Boston 🇺🇸 Next week, Hadil Es-Sbai, CEO at Triall, and Aman Khera, VP Global Head of Regulatory Strategy at Worldwide Clinical trials are hosting a presentation at the #DIA2023 Global Annual Meeting in Boston. The session will unpack the impact of blockchain-based technologies on the decentralization of clinical research and improvement of the patient experience. Time & location: ⏰ Monday June 26, 2023 4:15pm - 5:15pm EDT 📍 Room 253A Boston Convention and Exhibition Center More info:

sched.co

🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall Insights 🔍 According to the IQVIA Institute, 300 new molecular entities (‘NMEs’) are expected to be approved between 2022 and 2026. The influx of NMEs demonstrates the need for specialised software that supports reliable and cost-efficient clinical trials to bring these entities to market. ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Come visit our booth tomorrow at TNW 2023 🇳🇱 Triall will be present at TNW Conference 2023 on June 15-16 in Amsterdam. Like to know more about our #blockchain and Self-Sovereign Identity (#SSI) technologies and product vision? Come visit us at our booth (51S)! ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL #TNW2023

Check out our last AMA 📺💬 Triall hosts a monthly community AMA live on YouTube. In last month’s AMA, Triall CEO Hadil talks about our newest addition to the team, Arjan Groen! Arjan is an AI developer and data scientist who brings a strong background in Machine Learning and previously developed Deep Learning models for radiology and BI capabilities. Missed the live session? 👉 Check out the full recording: youtube.com/watch?v=o9Whlo6NYxA ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall will host a booth at TNW 🇳🇱 Our team will be attending TNW Conference 2023 on June 15-16 in Amsterdam. TNW Conference is one of the largest tech conferences in Europe, bringing together over 10,000 attendees from 120+ countries. The event provides a great opportunity to connect with industry leaders, KOLs, and investors to form partnerships and together build the future of tech. Also present? Come visit us at booth 51S on Thursday. ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL #TNW2023

Building the Clinical Insights Exchange (CIX) 🌐 We recently announced the upcoming prototype release of the federated clinical trial data marketplace that we’re developing in collaboration with Sphereon and the Dutch Blockchain Coalition. This marketplace will become a platform for advanced cryptographic techniques and AI models, allowing for privacy-friendly analysis over aggregated data from connected clinical trials and eClinical systems. 👇 Check out the full press release: dutchblockchaincoalition.org/en/news/triall-ontwikkelt-een-gefedereerde-marktplaats-voor-klinische-onderzoeksdata-2 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Did you catch our roadmap update? Last month, Triall presented a product roadmap update, focusing on the build & market introduction of the Clinical Insights Exchange (CIX). The CIX is a Web3 federated data marketplace where biopharma companies, clinicians, and patients can exchange research data & insights without having to share underlying data resources. It builds upon 5 years of R&D, including the development of blockchain and Self-Sovereign Identity (SSI) APIs, SDKs, infra, and components. This update marks Phase 3 of our long-term roadmap and entails the further integration of $TRL, which will be used as a primary means of access, benefit-sharing, and reimbursement. 👉 More info at bit.ly/TRLroadmap3 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

TRL is now tradable on MEXC 🚀 We’re happy to announce that our TRL / UDST (ERC-20) trading pair on MEXC Global is now open for trading! 📈 Link: mexc.com/exchange/TRL_USDT 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL #MEXC

TRL is listing on MEXC 🚀 We’re thrilled to share that $TRL will be listing on #MEXC! 🔹Pair: TRL/USDT (ERC-20) 🔹Trading: June 6, 08:00 UTC 🔹Location: mexc.com 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall AMA: Announcing the winners 🏆📺💬 Wow… we’ve truly been impressed by the quality of your AMA questions! After careful consideration, we’re excited to announce the winners of our 14th community AMA. AMA winner list @Pepayacc @Andromedamin @Opotatoo @sayuri1 @Sunsun77 How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: youtube.com/watch?v=o9Whlo6NYxA When is the next AMA? Our next community AMA will be hosted by the end of this month (date TBA). 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Product Spotlight: CIX catalogue 👩🏽‍💻 How will biopharma professionals and clinicians interact with the Clinical Insights Exchange (CIX)? Platform users will be able to search a federated catalogue of data assets and algorithms that fit their specific needs, filtering on properties such as therapeutic area, study phase, and geography. 👉 More info: bit.ly/TriallCIX1 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Product Spotlight: SSI wallet 📱🔍 Did you know about our SSI wallet? Triall aims to promote fair & equitable sharing of benefits among all stakeholders involved in clinical research Together with Sphereon, we are developing a SSI mobile wallet where patients can get reimbursed in $TRL each time they consent for re-use of their data in the CIX. 👉 Keep on reading: bit.ly/TriallCIX1 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

MayMilestones: Zooming in on the CIX - Part 1 🤖 Want a deep dive into our product vision & strategy? In this article, we’ll zoom in on the targeted features and benefits of the Clinical Insights Exchange (CIX), Self-Sovereign Identity (SSI) wallet, and $TRL token integration. We also describe our vision for TriallGPT, a chat agent that will enable even non-technical users to design compute jobs & obtain insights from CIX datasets. 👉 Keep on reading: bit.ly/TriallCIX1 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

And we’re live once again! 🚨📺💬 Tune in to this month’s live community AMA 👇

www.youtube.com

Circulating supply update ⚡️ Triall will soon be updating its circulating supply calculations based on community feedback and CMC guideline updates. This change better reflects the number of $TRL tokens owned by the community and available in the market. The following tokens will be calculated as part of the circulating supply: (1) Staked tokens: as staking is not locked and tokens are withdrawable; (2) Pre-sale tokens: as ITO pools are fully unlocked and withdrawable (by the community). 👉 Please note it may take some time before these changes are fully reflected by CMC and other trackers. 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall Insights 🔍 Gartner predicts that by year-end 2024, 75% of the world’s population will have its personal data covered under modern privacy regulations. This regulatory evolution has been the dominant catalyst for the operationalisation of privacy measures across industries. Triall’s CIX will become a platform for privacy-enhancing computation techniques, enabling decentralised and privacy-friendly reuse of clinical trial data. Source: bit.ly/3UDZoBa ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

MayMilestones: Upcoming prototype release 🦾 Together with the Dutch Blockchain Coalition (DBC) we officially announced the upcoming prototype release of the Clinical Insights Exchange (CIX). The CIX is a federated data marketplace that will become a platform for advanced cryptographic techniques & AI models, allowing for privacy-friendly analysis over aggregated clinical trial data. The CIX Web3 toolkit will incentivise industry & patient, with $TRL enabling P2P benefit-sharing & reimbursement. Nicky Hekster, Healthcare lead DBC: "As Triall unveils its ground-breaking CIX marketplace for clinical trials, it embarks on a transformative journey where decentralized technology meets healthcare innovation. This platform opens up new avenues for patient-centric research, empowering individuals to actively participate in shaping the future of healthcare." 👇 Press release: dutchblockchaincoalition.org/en/news/triall-ontwikkelt-een-gefedereerde-marktplaats-voor-klinische-onderzoeksdata-2 #blockchainforhealth

Announcing the next community AMA 📺💬 As we provide a growing number of updates on our platform, roadmap, and token over these weeks, it’s time for another video AMA to answer your most pressing questions! On May 30 at 13:00 UTC, Triall will host its 14th community AMA on YouTube, answering live and pre-submitted questions from the TRL community. 🎙 AMA Guests - Hadil Es-Sbai, Chief Executive Officer - Niels Klomp, Chief Technology Officer - Dr. Arno Bisschop, Chief Medical Officer - Raymond van der Waal, Head of Strategic Partnerships 📬 AMA Questions Submit your questions here: bit.ly/TRLvidAMA14 The 5 best questions get $50 in TRL tokens💰 🗣 Help us spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Triall Insights 🔍 According to a BMJ study that analysed 225 Phase 3 clinical trials, the median estimated cost per patient for a study amounted to $42,413. Costs were highest for drugs that required comparison with an already approved & effective drug and lowest for those where the FDA waived the requirements for a control group. Source: bmjopen.bmj.com/content/10/6/e038863.full ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

MayMilestones: Team expansion 🤝 Triall welcomes Arjan Groen as its newest addition to the team. Arjan is an AI developer and data scientist who will support Triall in the design, development, and validation of advanced (AI-enabled) analytics capabilities. He brings a unique combination of expertise with a strong background in Machine Learning, data science, and business intelligence (BI) applied to healthcare. Arjan is a published author on computer-aided diagnosis and has previously developed Deep Learning models for radiology as well as various BI capabilities. Arjan on Triall: “There is enormous unfulfilled potential for Data & AI in the health and life science sector. All that’s lacking is a secure and privacy-friendly way to exchange data & insights. Triall is solving this problem.” 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL #MayMilestones

Triall Insights 🔍 According to the IQVIA Institute, US venture capital deal value in biopharma reached $42B in 2022. Deal activity and investment flows in the US accelerated in the preceding 3 years as interest in Life Sciences intensified, with more than 2,000 deals occurring across 2022. Source: iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023 ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

MayMilestones: Triall invited to speak at DIA 2023 in Boston ✈️ Triall CEO Hadil has been invited to host two presentations at #DIA2023, the world’s premier biopharma event. DIA 2023 is a 5-day event that attracts industry professionals, regulators, and patient representatives from across the globe to network, problem-solve, and discuss key challenges. The event therefore offers a unique opportunity for us to present and validate our solutions and decentralised technology stack with a global audience of experts. Triall presentations: 📅 Blockchain-Based Technologies for Clinical Research: Distinguishing Myth from Reality 📅 The True Decentralization of Clinical Trials: Benefits and Drawbacks of Blockchain Technology 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL #MayMilestones

Triall Insights 🔍 According to Tufts CSDD, a typical Phase III clinical trial now includes 13 countries on average. This is a 39% increase compared to 2015, highlighting the further globalisation of clinical research. Triall offers purpose-built eClinical solutions that can be tailored to country-specific needs and requirements. Source: csdd.tufts.edu/impact-reports ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

MayMilestones: Roadmap update 🚀 We're excited to present an update on our product roadmap, focusing on the build and market introduction of the Clinical Insights Exchange (CIX). The CIX is a Web3 federated data marketplace where biopharma companies, clinicians, and patients can exchange research data & insights without having to share underlying data resources It builds upon 5 years of R&D, including the development of blockchain and Self-Sovereign Identity (SSI) APIs, SDKs, infra, and components. This update marks Phase 3 of our long-term roadmap and entails the further integration of $TRL, which will be used as a primary means of access, benefit-sharing, and reimbursement. 👉 Check out the roadmap: bit.ly/TRLroadmap3 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL #MayMilestones

Triall Insights 🔍 According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.8 endpoints. This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity. Triall is building data-driven solutions that help clinical research professionals design and operate complex clinical trial studies. Source: csdd.tufts.edu/impact-reports ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Announcing the MayMilestones series 🏆 Dear Triallians, We’re thrilled to announce the #MayMilestones series, a collection of high-impact updates on our software platform, technology roadmap, and utility token $TRL. Keep an eye on our channels and follow us on this transformative journey! MayMilestones calendar ☑️ W18 May 1-May 7: TBA ☑️ W19 May 8-May 14: TBA ☑️ W20 May 15-May 21: TBA ☑️ W21 May 22-May 28: TBA ☑️ W22 May 29-June 4: TBA ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

Fact of the day 🔍 9 out of 10 clinical trials worldwide can’t recruit enough people within their target timeframes. Some trials fail altogether for lack of enough participants. Triall aims to make participating in clinical research more attractive by devising novel ways to empower, compensate, and incentivise patients. Source: bit.ly/43VttQX 🗣 Help spread the news on Twitter:

twitter.com

#blockchainforhealth #TRL

#Gartner predicts that by 2025, 60% of large organisations will use at least one #privacy-enhancing computation (PEC) technique in analytics, business intelligence, and/or cloud computing. Source:

t.co

t.co

Announcing the AMA winners 🏆📺💬 We’re excited to announce the AMA winners of our 13th monthly community AMA live on YouTube. AMA winner list @Algojali @Pandalucu66 @peterson682 @Cassliu @KangKung70 How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: youtube.com/live/Trmr_M1BCO4 When is the next AMA? Our next community AMA will be hosted by the end of this month (date to be announced). #blockchainforhealth #TRL

Triall at Innovation for Health 2023 🇳🇱 Last week, Triall attended Innovation for Health, the largest Life Sciences innovation event in The Netherlands. The event's #startup #pitching competition allowed us to showcase our company and share the stage with other innovators 🔥

t.co

According to @TuftsCSDD, 119 protocol #deviations occur on average in a typical Phase 3 clinical trial. Triall offers an end-to-end #eClinical platform that harmonises and enforces protocol #compliance across all participating research sites. Source:

t.co

t.co

And we’re live once again! 🚨📺💬 Tune in to this month’s live #community #AMA 👇

t.co